Key facts
- Terry Duffy will step down as CEO of CME Group on March 1, 2027.
- Duffy will assume the role of Executive Chairman.
CME Group announced that CEO Terry Duffy will transition to Executive Chairman on March 1, 2027. Lynne Fitzpatrick, currently President and CFO, will become the new CEO and join the board.

The leadership transition at CME Group, a major global derivatives marketplace, signals a new era for the company after more than two decades under Terry Duffy's guidance, impacting its strategic direction and market operations.
CME Group, the world's leading derivatives marketplace, announced that its long-serving Chairman and Chief Executive Officer, Terry Duffy, will transition to the role of Executive Chairman on March 1, 2027. Duffy has been at the helm of the company for over 25 years, overseeing its transformation from floor-based trading to an electronic powerhouse and leading significant mergers and acquisitions.
Lynne Fitzpatrick, currently President and Chief Financial Officer, is slated to become the new Chief Executive Officer and will join the CME Group Board of Directors at the time of the transition. Fitzpatrick has over 20 years of strategic and financial expertise within the company.
Duffy expressed pride in leading CME Group through transformative growth and highlighted the company's strong position for the future. He stated his intention to work closely with Fitzpatrick to deliver enhanced benefits to clients and shareholders. Charlie Carey, Lead Director of the CME Group Board, thanked Duffy for his leadership and expressed confidence in Fitzpatrick's ability to continue expanding the company's leading position.